Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shelter PharmaBOM:543963 -2.26%66 Days Payable is 6.11 as of Mar. 2026, which is 13% above its 10-year median of 5.41. GuruFocus rates BOM:543963 with a GF Score™ of 66/100 and a GF Value™ of ₹57.02 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 926 Drug Manufacturers companies, Shelter Pharma ranks worse than 99.46% on this metric.
The historical data trend for Shelter Pharma's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shelter Pharma Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Days Payable distribution charts can be found below:
* The bar in red indicates where Shelter Pharma's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Shelter Pharma's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shelter Pharma (BOM:543963) has a Days Payable of 6.11 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shelter Pharma and its competitors. This is 13% above median its historical median of 5.41. Over the past decade, Shelter Pharma's Days Payable has ranged from 3.34 to 9.68. According to the industry distribution chart, Shelter Pharma ranks #921 out of 926 companies in the Drug Manufacturers industry, placing it in the top 99.5%.
Is Shelter Pharma's Days Payable too high?
Shelter Pharma's current Days Payable of 6.11 is 13% above median its 10-year median of 5.41. Over the past 10 years, this metric has ranged from a low of 3.34 to a high of 9.68. The Drug Manufacturers industry median Days Payable is 90.22. Shelter Pharma's value of 6.11 is 93.2% below this industry median. Based on the distribution chart, Shelter Pharma ranks #921 out of 926 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shelter Pharma has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shelter Pharma's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shelter Pharma ranks #921 out of 926 companies for Days Payable. This places Shelter Pharma in the lower half of its industry. The industry median Days Payable is 90.22. Shelter Pharma's value of 6.11 is 93.2% below this benchmark. Historically, Shelter Pharma's own Days Payable has ranged from 3.34 to 9.68 over the past decade. While the company's 10-year median is 5.41 vs. the industry median of 90.22, Shelter Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.22, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shelter Pharma's current Days Payable of 6.11 is 93.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shelter Pharma and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shelter Pharma's current Days Payable is 6.11, which is 13% above median its own 10-year median of 5.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shelter Pharma stock overvalued right now?
Based on GuruFocus' analysis, Shelter Pharma (BOM:543963) is currently considered Possible Value Trap. The stock's GF Value™ is ₹57.02, compared to a current price of ₹26.00 — trading 54.4% below its estimated fair value. The current Days Payable is 6.11, which is 13% above median its 10-year median of 5.41 and 93.2% below the Drug Manufacturers industry median of 90.22. Shelter Pharma's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shelter Pharma (BOM:543963), the current Days Payable is 6.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shelter Pharma (BOM:543963) Overvalued in 2026?
Based on GuruFocus' analysis, Shelter Pharma stock appears to be undervalued.
The current stock price of ₹26.00 is trading 54.4% below its estimated GF Value™ of ₹57.02.
GuruFocus considers Shelter Pharma to be Possible Value Trap.
Key valuation signals for BOM:543963:
Days Payable: 6.11 (13% above median its 10-year median of 5.41)
GF Value™: ₹57.02 vs. price of ₹26.00 (54.4% below fair value)
Industry Position: 93.2% below the Drug Manufacturers median (#921 of 926)
No single metric tells the full story. See the BOM:543963 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in majority of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.
66GF Score
Get the complete analysis for BOM:543963
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543963 has been successfully added to your 
